180 Life Sciences Corp.

NASDAQ: ATNF · Real-Time Price · USD
7.09
-0.52 (-6.83%)
At close: Aug 15, 2025, 3:59 PM
7.20
1.55%
After-hours: Aug 15, 2025, 07:58 PM EDT

180 Life Sciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-9.21M -7.47M -6.17M -3.12M -12.55M -16.24M -19.94M -40.45M -51.67M -45.05M -38.73M -15.95M 23.84M -2.56M -20.32M -29.3M -48.43M -24.7M
Depreciation & Amortization
10.72K 34.7K 58.28K 84.07K 102.91K 107.48K 105.67K 120.62K 95.9K 104.31K 109K 88.2K 115.18K 107.74K 109.95K 124.99K 121.22K 121.71K
Stock-Based Compensation
49.8K 72.11K 308.17K 804.8K 1.43M 1.96M 2.28M 2.38M 2.35M 2.59M 2.63M 2.98M 2.81M 2.36M 2.85M 2.99M 5.18M 4.84M
Other Working Capital
1.97M 2.07M 1.56M -908.48K -1.01M -1.2M -300.51K 2.71M 2.91M 2.09M 1.51M -1.04M -284.28K -1.34M -3.08M -3.34M -3.72M -1.99M
Other Non-Cash Items
3.72M 3.46M 2.88M -199.82K 3.98M 4.14M 4.08M 21.19M 34.53M 27.12M 22.08M -677.1K -40.21M -12.33M 6.82M 17.27M 35.95M 14M
Deferred Income Tax
-292.42K -292.42K -292.42K -4.66K 2.57M 2.56M 2.56M 1.62M -954.36K -920.42K -942.75K -8.22K -13.83K -41.73K -24.8K -21.84K -21.36K -20.73K
Change in Working Capital
2.56M 2.89M 1.73M -252.53K 224.47K -603.92K -14.1K 3.45M 2.14M 2.23M 2.72M -667.3K -1.17M -2.64M -8.81M -8.62M -6.41M -4.03M
Operating Cash Flow
-3.16M -1.3M -1.48M -2.69M -4.24M -8.09M -10.92M -11.69M -13.51M -13.92M -12.13M -14.23M -14.63M -15.11M -19.37M -17.56M -13.61M -9.79M
Capital Expenditures
7.00 3.00 -3 1.00 -4 -4 -1 -5 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 3.01M 3.01M 3.01M
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -15.19K -15.19K -15.19K -15.19K 11.48M 11.48M 11.48M
Investing Cash Flow
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -15.19K -15.19K -15.19K -15.19K 14.49M 14.49M 14.49M
Debt Repayment
-1.16M -1.07M -1.33M -308.75K -90.31K -83.14K -288.07K -104.61K -329.2K -565.81K -611.42K 57.06K 388.15K -83.1K 63.78K -1.51M -1.21M -237.13K
Common Stock Repurchased
1M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -9.01M -10.17M -10.17M
Dividend Paid
-8.01M -8.01M -8.01M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -2.92M -2.92M -2.92M
Other Financial Acitivies
10.81M 10.81M 10.81M n/a -294.91K -294.91K -294.91K -294.91K n/a n/a n/a n/a -1.12M -1.32M -1.32M 1.41M 2.53M 2.73M
Financial Cash Flow
4.21M 4.3M 4.04M 462.99K 3.39M 6.11M 5.91M 10.84M 13.88M 10.92M 10.87M 6.03M 14.27M 14.53M 25.41M 14.64M 1.06M 1.3M
Net Cash Flow
1.07M 3.05M 2.61M -2.47M -862.32K -1.97M -4.99M -926.12K 383.37K -3.02M -1.25M -8.1M -210.4K -383.95K 6.12M 11.66M 1.77M 5.96M
Free Cash Flow
-3.16M -1.3M -1.48M -2.69M -4.24M -8.09M -10.92M -11.69M -13.51M -13.92M -12.13M -14.23M -14.63M -15.11M -19.37M -17.56M -13.61M -9.79M